N-[5-methyl-2-(2,3-dihydro-1H-indol-1-yl)phenyl]-4-methyl-1-piperazinecarboxamide → 1H-1,4-Benzodiazepine

HRID 35104

반응식

HRID 35104 반응식
CC1C=C[C:5]([N:18]2[C:26]3[C:21](=[CH:22][CH:23]=[CH:24][CH:25]=3)[CH2:20]C2)=[C:6]([NH:8]C(N2CCN(C)CC2)=O)C=1>P(Cl)(Cl)(Cl)=O>[NH:18]1[C:26]2[CH:25]=[CH:24][CH:23]=[CH:22][C:21]=2[CH:20]=[N:8][CH:6]=[CH:5]1

참가 물질

3

실험 절차

A stirred mixture of 35.1 (0.10 mole) of N-[5-methyl-2-(2,3-dihydro-1H-indol-1-yl)phenyl]-4-methyl-1-piperazinecarboxamide of Example 5c in 500 ml of phosphorus oxychloride was refluxed for 6 hours under nitrogen, then cooled to room temperature. The excess phosphorus oxychloride was removed at aspirator pressur with gentle warming. The residue was chilled in an ice-bath (with exclusion of moisture), and then treated first with 250 ml of ice-cold 2N-NaOH, then with 500 ml of chloroform. The mixture was stirred vigorously until all the material passed into solution. The organic phase was separated, washed thrice with water, and concentrated in vacuo to an oil. This was dissolved in 100 ml of boiling acetone, then allowed to crystallize at room temperature to afford 13.5 9 (41% overall yield) of 9-methyl-6-(4-methyl-1-piperazinyl)-1,2-dihydrobenzo[b]pyrrolo 3,2,1-jk][1,4]-benzodiazepine, m.p. 160°-162° C.

후처리

  1. temperaturewas refluxed for 6 hours under nitrogen
  2. customThe excess phosphorus oxychloride was removed at aspirator pressur with gentle warming
  3. temperatureThe residue was chilled in an ice-bath (with exclusion of moisture)
  4. additiontreated first with 250 ml of ice-cold 2N-NaOH
  5. customThe organic phase was separated
  6. washwashed thrice with water
  7. concentrationconcentrated in vacuo to an oil
  8. dissolutionThis was dissolved in 100 ml of boiling acetone
  9. customto crystallize at room temperature

출처 및 근거

ORD 기록
ord-a36db1fff1f94eeb8c4e60e92323e55b
출처 데이터셋
uspto-grants-1988_08
특허 번호
US04764616

연결된 노트

불러오는 중…